Neuberger Berman Group LLC Boosts Position in Humana Inc. $HUM

Key Points

• Neuberger Berman dramatically increased its stake in Humana, boosting holdings by 2,855.5% to 530,775 shares—about 0.44% of the company—worth roughly $138.09 million per its latest SEC filing.
• Quarterly results beat expectations: Humana reported EPS of -$3.96 vs. a consensus of -$4.01 and revenue of $32.64 billion (up 11.3% YoY), and the company set FY2026 EPS guidance at 9.00 while analysts forecast ~16.47 EPS for the current year.
• Humana declared a quarterly dividend of $0.885 per share (annualized $3.54, ~2.0% yield) with an ex-dividend date of March 27 and payment on April 24, and insider Sanjay K. Shetty recently bought 810 shares.

Neuberger Berman Group LLC boosted its holdings in Humana Inc. (NYSE:HUM - Free Report) by 2,855.5% in the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 530,775 shares of the insurance provider's stock after purchasing an additional 512,816 shares during the quarter. Neuberger Berman Group LLC owned about 0.44% of Humana worth $138,092,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the stock. Elevation Point Wealth Partners LLC purchased a new stake in shares of Humana during the 2nd quarter worth approximately $32,000. Mather Group LLC. purchased a new position in shares of Humana in the 3rd quarter valued at $34,000. AlphaCore Capital LLC acquired a new stake in Humana during the 2nd quarter worth $39,000. Private Wealth Management Group LLC raised its stake in Humana by 47.5% during the 3rd quarter. Private Wealth Management Group LLC now owns 149 shares of the insurance provider's stock worth $39,000 after acquiring an additional 48 shares in the last quarter. Finally, SJS Investment Consulting Inc. lifted its position in Humana by 19,300.0% in the third quarter. SJS Investment Consulting Inc. now owns 194 shares of the insurance provider's stock valued at $50,000 after acquiring an additional 193 shares during the last quarter. Institutional investors and hedge funds own 92.38% of the company's stock.

Humana Price Performance

Humana stock opened at $179.27 on Friday. The company has a debt-to-equity ratio of 0.70, a current ratio of 2.00 and a quick ratio of 2.00. The business has a 50 day simple moving average of $221.75 and a 200-day simple moving average of $252.52. Humana Inc. has a 12 month low of $169.61 and a 12 month high of $315.35. The stock has a market capitalization of $21.62 billion, a PE ratio of 18.26, a price-to-earnings-growth ratio of 1.95 and a beta of 0.44.

Humana (NYSE:HUM - Get Free Report) last announced its quarterly earnings data on Wednesday, February 11th. The insurance provider reported ($3.96) earnings per share (EPS) for the quarter, beating the consensus estimate of ($4.01) by $0.05. The company had revenue of $32.64 billion for the quarter, compared to analysts' expectations of $32.08 billion. Humana had a net margin of 0.92% and a return on equity of 11.43%. Humana's revenue was up 11.3% compared to the same quarter last year. During the same period in the previous year, the company posted ($2.16) EPS. Humana has set its FY 2026 guidance at 9.000-9.000 EPS. Equities analysts predict that Humana Inc. will post 16.47 earnings per share for the current year.

Humana Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, April 24th. Stockholders of record on Friday, March 27th will be paid a dividend of $0.885 per share. This represents a $3.54 dividend on an annualized basis and a dividend yield of 2.0%. The ex-dividend date is Friday, March 27th. Humana's payout ratio is 36.05%.

Insider Transactions at Humana

In other news, insider Sanjay K. Shetty purchased 810 shares of the business's stock in a transaction that occurred on Monday, February 23rd. The stock was purchased at an average cost of $185.21 per share, with a total value of $150,020.10. Following the completion of the acquisition, the insider directly owned 11,657 shares of the company's stock, valued at approximately $2,158,992.97. This trade represents a 7.47% increase in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. 0.37% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades

Several brokerages have issued reports on HUM. Weiss Ratings reaffirmed a "sell (d+)" rating on shares of Humana in a report on Thursday, January 22nd. UBS Group reissued a "neutral" rating on shares of Humana in a report on Wednesday, February 25th. Morgan Stanley set a $146.00 target price on Humana in a research report on Thursday, February 12th. Leerink Partners dropped their price target on Humana from $267.00 to $185.00 and set a "market perform" rating on the stock in a research note on Thursday, February 12th. Finally, Guggenheim reduced their price objective on Humana from $312.00 to $252.00 and set a "buy" rating for the company in a research note on Thursday, February 12th. Seven analysts have rated the stock with a Buy rating, sixteen have assigned a Hold rating and three have assigned a Sell rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of "Hold" and an average target price of $225.48.

About Humana

Humana Inc NYSE: HUM is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana's products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.

Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUM - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.